-

Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy

MONTREAL--(BUSINESS WIRE)--Innovaderm, a leading clinical research organization (CRO) specializing in dermatology and rheumatology, is pleased to announce the appointment of Ina Zschocke, as the new Executive Vice President, European Operations and Strategy. This strategic hire underscores Innovaderm’s commitment to expanding its ever-growing presence and capabilities in the European market.

Ina Zschocke, PhD, MDRA brings more than 20 years of clinical research expertise, particularly in dermatology, allergology, and aesthetics. In her previous role as head of Dermatology, Immunology, and Inflammatory Diseases, she developed strategies for conducting high-quality clinical trials for emerging biopharma clients. Before this, Ina held various academic research positions and founded SCIderm, an international dermatology CRO, which she successfully led for 15 years until its acquisition.

“I am excited to join Innovaderm and look forward to contributing to the company’s success in Europe,” said Ina Zschocke. “Innovaderm’s dedication to innovation and excellence in dermatology and rheumatology research aligns perfectly with my professional values and goals.”

With the addition of Ina Zschocke, Innovaderm aims to enhance its operational efficiency and client service in Europe. She will be responsible for overseeing all European operations and contributing to business growth efforts. Moreover, Innovaderm is thrilled to highlight its attention on rheumatology, further broadening its research capabilities and commitment to advancing medical knowledge and elaborating new therapies.

“We are thrilled to welcome Ina Zschocke to our team,” said Dr. Robert Bissonnette, CEO of Innovaderm. “Her extensive experience and proven track record in the industry make her an invaluable asset as we continue to expand our footprint in Europe and strengthen our focus on rheumatology.”

For more information about our resources please visit: https://innovaderm.com/full-service-dermatology-cro/

Innovaderm Research Inc.

Innovaderm Research Inc. is a specialized CRO with a dual focus on dermatology and rheumatology. We assist biopharmaceutical sponsors in initiating and completing clinical trials. With over 25 years of globally recognized expertise in dermatology and clinical operations, an extensive and continually expanding network of clinicians and sites, and a dedicated research clinic, Innovaderm offers a highly informed, focused, and comprehensive approach to addressing niche clinical needs in dermatology and rheumatology.

Contacts

For more information:
Valerie Coveney
Communications Specialist
Innovaderm Research Inc.
vcoveney@innovaderm.com

Innovaderm Research Inc.



Contacts

For more information:
Valerie Coveney
Communications Specialist
Innovaderm Research Inc.
vcoveney@innovaderm.com

More News From Innovaderm Research Inc.

Innovaderm Research Rebrands as Indero, a Dual-Focus CRO

MONTREAL--(BUSINESS WIRE)--Innovaderm, a leading clinical research organization (CRO), is excited to reveal a major rebranding to Indero, with immediate effect. The new brand identity reinforces the company’s dual focus on rheumatology and dermatology and recognizes the close synergy between these fields. Innovaderm has over 25 years of clinical research experience within dermatology, and recognizes that many inflammatory and autoimmune conditions manifest across both the skin and the musculosk...

Innovaderm Research, a Dual Focus CRO, Appoints Jeff Smith as New CEO

MONTREAL--(BUSINESS WIRE)--Innovaderm Research, a leader in dermatological and rheumatological research, is proud to announce the appointment of Jeff Smith as the new CEO of the organization. This strategic change allows Innovaderm’s founder and former CEO, Dr. Robert Bissonnette, to fully dedicate himself to his role as Executive Chairman of Innovaderm, providing medical and scientific support to the CRO and its clients. Jeff brings nearly 30 years of experience in the pharmaceutical and CRO i...

Innovaderm Research Welcomes Dr Juan Gabriel Ovalles Bonilla, MD, PhD as Medical Rheumatology Lead, Expanding its Reach into this Field

MONTREAL--(BUSINESS WIRE)--Innovaderm Research, a leader in dermatological research, is pleased to announce the appointment of Juan Gabriel Ovalles Bonilla, MD, PhD, a seasoned Europe-based board-certified rheumatologist, to its team. Dr Ovalles’ experience and expertise marks Innovaderm’s expansion into the field of rheumatology, furthering its commitment to advancing research and patient care in systemic autoimmune disease. Dr Ovalles brings 12+ years of clinical research expertise and a back...
Back to Newsroom